338 related articles for article (PubMed ID: 33693987)
1. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
2. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
Coriati A; Ziai S; Lavoie A; Berthiaume Y; Rabasa-Lhoret R
Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
[TBL] [Abstract][Full Text] [Related]
3. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of glucose intolerance in cystic fibrosis.
Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
[TBL] [Abstract][Full Text] [Related]
5. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
6. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
[TBL] [Abstract][Full Text] [Related]
7. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
8. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
[TBL] [Abstract][Full Text] [Related]
10. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
13. A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children with Cystic Fibrosis.
Potter KJ; Racine F; Bonhoure A; Boudreau V; Bélanger N; Coriati A; Shohoudi A; Lavoie A; Senior PA; Mailhot G; Rabasa-Lhoret R
Diabetes Metab; 2023 Jul; 49(4):101455. PubMed ID: 37271306
[TBL] [Abstract][Full Text] [Related]
14. Association of the relative change in weight and body mass index with lung function in teenagers and adults with cystic fibrosis: Influence of gender and diabetes.
Cano Megías M; Guisado Vasco P; González Albarrán O; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Nov; 62(9):422-9. PubMed ID: 26311609
[TBL] [Abstract][Full Text] [Related]
15. β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL.
Nyirjesy SC; Sheikh S; Hadjiliadis D; De Leon DD; Peleckis AJ; Eiel JN; Kubrak C; Stefanovski D; Rubenstein RC; Rickels MR; Kelly A
Pediatr Diabetes; 2018 Nov; 19(7):1173-1182. PubMed ID: 29885044
[TBL] [Abstract][Full Text] [Related]
16. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
17. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
Chan CL; Pyle L; Vigers T; Zeitler PS; Nadeau KJ
J Clin Endocrinol Metab; 2022 Jan; 107(2):e548-e560. PubMed ID: 34537845
[TBL] [Abstract][Full Text] [Related]
18. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
[No Abstract] [Full Text] [Related]
19. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
[TBL] [Abstract][Full Text] [Related]
20. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET).
Coriati A; Ziai S; Azar M; Berthiaume Y; Rabasa-Lhoret R
J Cyst Fibros; 2016 Jan; 15(1):127-32. PubMed ID: 25818059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
